-
ChemGenex Pharmaceuticals (Acq 2011)...
- (1).
Harvard University Press: 24–39. Bennett,
Simeon (2008-04-03). "
ChemGenex Poised for
Rebound With Merck-Beating Drug (Update4)". Bloomberg. Archived...
-
seizure disorder medication Gabitril. In 2011,
Cephalon agreed to
acquire ChemGenex Pharmaceuticals,
which would provided Cephalon with
marketing rights to...
-
approaches were
developed to the
treatment of CML as a result: In 2007,
Chemgenex released results of an open-label
Phase 2/3
study (CGX-635-CML-202) that...
- company, Nephro
Genex In 2008, Nephro
Genex restarted the
clinical development of Pyridorin,
which as of 2012 is
still ongoing. Nephro
Genex conducted and...
- clinically. It is sold
under the
trade name
Periostat by the
company Colla
Genex. Minocycline,
another tetracycline antibiotic, has also been
shown to inhibit...
-
North America and Asia.
ThalesNano was spun out of Com
Genex, Inc in 2002 to
commercialize Com
Genex’s innovations in the
areas of microfluidics, mesofluidics...
- Chemistry. 8 (3): 305–16. doi:10.2174/0929867013373598. PMID 11172685. "Colla
Genex says
incyclinide ineffective for rosacea". Reuters. 26
September 2016. Retrieved...
-
developed through a
collaboration between Onco
Genex Pharmaceuticals Inc. and Isis. In 2009, Onco
Genex Pharmaceuticals Inc. and Teva
Pharmaceutical Industries...
-
traditional tetracyclines, it
lacks antibiotic properties. Reuters: Colla
Genex says
incyclinide ineffective for
rosacea Spreitzer H (2 July 2007). "Neue...
